SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 1, 2002
---------------------
PACIFICHEALTH LABORATORIES, INC.
--------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-23495 22-3367588
-------- --------- ----------
(State or other jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
1480 Route 9 North, Suite 204, Woodbridge, New Jersey 07095
----------------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 732/636-6141
-----------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Items.
I. Appointment of New Director
Effective April 1, 2002, PacificHealth Laboratories, Inc.
(the"Company") increased the size of its Board of Directors from five to six and
elected Michael E. Cahr as a director of the Company to fill the vacancy thus
created. Mr. Cahr is currently President of Saxony Consultants, a company that
provides financial and marketing expertise to organizations in the United States
and abroad. For the two-year period, February 2000 to March 2002, Mr. Cahr
served as President and Chief Executive Officer of Ikadega, Inc., a Northbrook,
Illinois server technology company developing products and services for the
healthcare, data storage and hospitality fields. He was Chairman of Allscripts,
Inc., the leading developer of hand-held devices that provide physicians with
real-time access to health, drug and other critical information from September
1997 through March 1999 and President, CEO and Chairman from June 1994 to
September 1997. Prior to Allscripts, Mr. Cahr was Venture Group Manager for
Allstate Venture Capital where he oversaw investments in technology, healthcare
services, biotech and medical services from October, 1987 to June 1994. Mr. Cahr
serves as a director of Lifecell Corporation, a Branchburg, New Jersey-based,
publicly traded tissue engineering company where he has been a board member
since 1991. He is also a director of Metropolitan Health Networks, a West Palm
Beach, Florida-based public healthcare network management and pharmacy
organization as well as a director of Truswal Systems, an Arlington, Texas-based
software engineering firm.
II. Annual Meeting Date and Stockholder Proposals
The Company has fixed the date, time, location and record date for the
annual meeting of the stockholders of the Company for the 2001 fiscal year. The
Company has determined that the annual meeting will be held on Tuesday, June 18,
2002 at 10:00 a.m. (local time) at the Woodbridge Hilton, 120 Wood Avenue South,
Iselin, New Jersey, 08830. The Company also established the close of business on
May 10, 2002 as the record date for the determination of stockholders entitled
to receive notice of, and to vote at, the annual meeting and any adjournment or
postponement thereof. The change in date does not affect the March 27, 2002
deadline for stockholder proposals to be presented at the 2002 Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PACIFICHEALTH LABORATORIES, INC.
Dated: April 10, 2002 By: /s/ Robert Portman
-------------------------
Robert Portman, President